Iron Overload and Platelet Function Defects: Possible Correlation

Abdulkader A Dahi1, Ehab Hanafy1, Mohammed Al Pakra1

  • 1King Salman Armed Forces Hospital, Tabuk, Kingdom of Saudi Arabia.

Insights

Iron overload from chronic transfusions may cause acquired platelet dysfunction, leading to bleeding. Screening platelet function in transfusion patients is recommended to prevent severe bleeding events.

Area of Science:

  • Hematology
  • Pediatrics
  • Iron Metabolism

Background:

  • Iron overload is a known complication of chronic blood transfusions.
  • Platelet dysfunction is rarely reported as a complication of iron overload.
  • Diamond-Blackfan anemia requires chronic transfusions, increasing iron overload risk.

Purpose of the Study:

  • To investigate the potential link between iron overload and acquired platelet function defect.
  • To highlight a case of Diamond-Blackfan anemia with this complication.

Main Methods:

  • Case report of a child with Diamond-Blackfan anemia.
  • Clinical observation of complications related to chronic blood transfusions and iron overload.
  • Assessment of platelet function in the context of iron overload.

Main Results:

  • The patient presented with acquired platelet function defect.
  • Frequent epistaxis episodes were observed, consistent with platelet dysfunction.
  • This complication was attributed to significant iron overload from chronic transfusions.

Conclusions:

  • Acquired platelet function defect may be a consequence of iron overload.
  • Further research is needed to confirm the direct correlation between iron overload and platelet dysfunction.
  • Screening platelet function in patients with chronic transfusions is recommended for bleeding prevention.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.6K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.7K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.3K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
90